Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Adding low-dose IV ketamine to spinal anesthesia to prolong numbness for lower-limb surgery in older adults

Official title: Effect of Intravenous Ketamine Combined With Spinal Anesthesia on Sensory Block Duration Compared to Spinal Anesthesia Alone in Lower Limb Surgeries in Geriatrics: A Randomized Controlled Double-Blinded Trial.

Run by Cairo University · NCT07520487 · Data updated 2026-11-12

This test will see if giving a small IV ketamine bolus and infusion with spinal anesthesia prolongs the sensory block in people aged 65 and older having elective lower‑limb surgery.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment61 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Giza Governorate)
StatusRecruiting
StartedApril 25, 2026
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedApril 30, 2026
Trial IDNCT07520487 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 65 years or older of either sex with ASA physical status I–III scheduled for elective lower‑limb surgery in the supine position under spinal anesthesia are ideal candidates.

Probably not a fit

Patients with coagulopathy, preexisting neurological disorders, local infection at the puncture site, known hypersensitivity to the drugs used, or who are unwilling to participate are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Older adults scheduled for elective lower‑limb surgery under spinal anesthesia will receive standard spinal anesthesia with hyperbaric bupivacaine 0.5% and be assigned to either an IV ketamine arm (0.2 mg/kg bolus diluted to 5 ml followed by 0.1 mg/kg/hr infusion) or a placebo saline arm (5 ml bolus followed by matching infusion). The primary outcome is duration of sensory block measured by dermatome level over time after spinal injection. Secondary observations include postoperative analgesia requirements and hemodynamic/neurologic safety in the geriatric population. The protocol excludes patients with coagulopathy, preexisting neurologic disorders, local infection at the needle site, known drug allergies, or those who refuse participation.

Why it matters

Potential benefit: If successful, adding low‑dose IV ketamine could prolong postoperative sensory block, reduce opioid needs, and improve pain control after lower‑limb surgery in older adults.

How similar studies have gone: Some prior perioperative ketamine studies have shown reduced opioid use and prolonged analgesia, but IV ketamine specifically combined with spinal bupivacaine in geriatric lower‑limb surgery is relatively under‑studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 65 years and older

  * Both sexes
  * American Society of Anesthesiologists (ASA) physical status I, II, III
  * Scheduled for elective lower limb surgeries under spinal anesthesia in supine position

Exclusion Criteria:

* Patient's refusal.

  * Pre-existing neurological disorders.
  * Coagulopathy (i.e., Platelets ≤ 60,000 and/or INR\> 1.5).
  * Localized infection at the site of needle insertion.
  * Known hypersensitivity or allergies to any of the used drugs

Where it's running

  • Cairo university hospitals
    Cairo, Giza Governorate, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.